ERBB2 and breast carcinoma: In this sense, breast cancer and its molecular subtypes, Luminal A, Luminal B, HER2+, and Basal-like (17, 18), are an emblematic example because they have distinct patterns of gene co-expression profiles and lead to different breast cancer manifestations both at the molecular and clinical levels.